Stanley Erck
Förmögenhet: 480 199 $ per 2026-09-30
Förmögenhet: 480 199 $ per 2026-09-30
Stanley C.
Erck is currently an Independent Non-Executive Director at MaxCyte, Inc. since 2005 and an Executive Director at Learning Undefeated, Inc. since 2014.
Formerly, Mr. Erck was President, Chief Executive Officer & Director at Novavax, Inc. from 2011 to 2023; President, Chief Executive Officer & Director at Procept, Inc.; President, Chief Executive Officer & Director at Valneva Usa, Inc. (United States) from 2000 to 2008; Independent Director at BioCryst Pharmaceuticals, Inc. from 2008 to 2018; Head-Global Regulatory Affairs Vaccines at Baxter International, Inc.; and Vice President-Corporate Development at Integrated Genetics, Inc. Education includes undergraduate studies at the University of Illinois and an MBA from The University of Chicago Booth School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
MAXCYTE, INC. 0,42 % | 2026-06-17 | 428 749 ( 0,42 % ) | 480 199 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| MAXCYTE, INC. | Direktör/Styrelseledamot | 2005-01-01 |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktör/Styrelseledamot | 2009-05-13 |
| Företag | Position | Slut |
|---|---|---|
| NOVAVAX, INC. | Verkställande Direktör | 2023-01-23 |
| BIOCRYST PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2018-12-03 |
| IOMAI CORPORATION | Verkställande Direktör | 2008-01-01 |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Företagsledare/Principal | - |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Välj din utgåva
All finansiell information anpassad till den nationella nivån